Skip to main content
Log in

Antibiotic Considerations for Urinary Tract Infections in Pregnancy

  • Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Urinary tract infections are one of the most common infections in pregnant women and may produce important consequences in the mother and fetus. Prompt diagnosis and treatment are necessary to avoid those adverse events, but antibiotic drugs are not lacked of risk. Various teratogenic or toxic effects have been described with their use. Currently, there are no sufficient data to recommend a standard regimen to treat these infections. Betalactams, nitrofurantoins, or fosfomycins are appropriate regimens when based on the culture sensitivity, but the increasing problem of antibiotic resistance makes the selection more difficult.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Grabe M, Bjerklund-Johansen TE, Botto H, Çek M, Naber KG, Pickard RS, et al. Guidelines on urological infections. European Association of Urology. 2013. These guidelines summarize recommendations for the management of urinary tract infections and asymptomatic bacteriuria in pregnant women.

  2. Bérard A, Santos F, Ferreira E, Perreault S. Urinary tract infections during pregnancy, urinary tract infections. Dr. Peter Tenke (Ed.), 2011. ISBN: 978-953-307-757-4, InTech, Available from: http://www.intechopen.com/books/urinary-tract-infections/urinary-tract-infections-during-pregnancy. This is an excellent review of all the current evidence regarding urinary tract infections in pregnancy.

  3. FitzGerald MP, Graziano S. Anatomic and functional changes of the lower urinary tract during pregnancy. Urol Clin N Am. 2007;34:7–12.

    Article  Google Scholar 

  4. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl 1A):5S–13.

    Article  PubMed  Google Scholar 

  5. Schnarr J, Smaill F. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur J Clin Investig. 2008;38(S2):50–7.

    Article  Google Scholar 

  6. Dwyer PL, O’Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol. 2002;14(5):537–43.

    Article  PubMed  Google Scholar 

  7. Lee M, Bozzo P, Einarson A, Koren G. Urinary tract infections in pregnancy. Can Fam Physician. 2008;54:853–4.

    PubMed Central  PubMed  Google Scholar 

  8. Harris RE, Gilstrap 3rd LC. Cystitis during pregnancy: a distinct clinical entity. Obstet Gynecol. 1981;57:578–80.

    CAS  PubMed  Google Scholar 

  9. The National Archives. Hospital Episode Statistics, Department of Health, England, 2002–03

  10. American Academy of Pediatrics and American College of Obstetricians and Gynecology. Guidelines for perinatal care. American Academy of Pediatrics. (2007); 6th ed.

  11. Lumbiganon P, Laopaiboon M, Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol. 2010;22:95–9.

    Article  PubMed  Google Scholar 

  12. Smaill F. Asymptomatic bacteriuria in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):439–50.

    Article  PubMed  Google Scholar 

  13. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst. Rev. (2), CD000490 (2007). doi: 10.1002/14651858.CD000490.pub2

  14. Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol. 2009;19:368–74.

    Article  PubMed  Google Scholar 

  15. Jolley JA, Wing DA. Pyelonephritis in pregnancy: an update on treatment options for optimal outcomes. Drugs. 2010;70:1643–55.

    Article  CAS  PubMed  Google Scholar 

  16. Hill JB, Sheffield JS, McIntire DD, Wendel Jr GD. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105:18–23.

    Article  PubMed  Google Scholar 

  17. Sheffield JS, Cunningham FG. Urinary tract infection in women. Obstet Gynecol. 2005;106:1085–92.

    Article  PubMed  Google Scholar 

  18. Jeyabalan A, Lain KY. Anatomic and functional changes of the upper urinary tract during pregnancy. Urol Clin N Am. 2007;34:1–6.

    Article  Google Scholar 

  19. Johnson EK, Wolf JS Jr, Kim ED, Ghoniem GM, Jones LA, Noble MJ, et al.: Urinary tract infections in pregnancy medication. Medscape. Updated: Feb 5, 2014.

  20. Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infections during pregnancy. Ann Pharmacother. 2004;38(10):1692–701.

    Article  PubMed  Google Scholar 

  21. Roos V, Nielsen EM, Klemm P. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. FEMS Microbiol Lett. 2006;262:22–30.

    Article  CAS  PubMed  Google Scholar 

  22. Nowicki B. Urinary tract infection in pregnant women: old dogmas and current concepts regarding pathogenesis. Curr Infect Dis Rep. 2002;4:529–35.

    Article  PubMed  Google Scholar 

  23. Nowicki B, Sledzinska A, Samet A, Nowicki S. Pathogenesis of gestational urinary tract infection: urinary obstruction versus immune adaptation and microbial virulence. BJOG. 2011;118:109–12.

    Article  CAS  PubMed  Google Scholar 

  24. Gilbert NM, O’Brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Glob Adv Health Med. 2013;2(5):59–69.

    Article  PubMed  Google Scholar 

  25. Fatima N, Ishrat S. Frequency and risk factors of asymptomatic bacteriuria during pregnancy. J Coll Physicians Surg Pak. 2006;16:273–5.

    PubMed  Google Scholar 

  26. Turiani M. Habitos de Higiene Genital e Infeccao autorreferida no trato urinario na gravidez Escola de Enfermagem. Sao Paulo: Universidade de Sao Paulo; 2009. p. 94.

    Google Scholar 

  27. McDermott S, Daguise V, Mann H, Szwejbka L, Callaghan W. Perinatal risk for mortality and mental retardation associated with maternal urinary-tract infections. J Fam Pract. 2001;50:433–7.

    CAS  PubMed  Google Scholar 

  28. Christensen B. Use of antibiotics to treat bacteriuria of pregnancy in the Nordic countries. Which antibiotics are appropriate to treat bacteriuria of pregnancy? Int J Antimicrob Agents. 2001;17:283–5.

    Article  CAS  PubMed  Google Scholar 

  29. Sheiner E, Mazor-Drey E, Levy A. Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonatal Med. 2009;22(5):423–7.

    Article  PubMed  Google Scholar 

  30. Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis. 1992;14:927–32.

    Article  CAS  PubMed  Google Scholar 

  31. Duarte G, Marcolin AC, Quintana SM, Cavalli RC. Urinary tract infection in pregnancy. Rev Bras Ginecol Obstet. 2008;30:93–100.

    PubMed  Google Scholar 

  32. Bolton M, Horvath Jr DJ, Li B, Cortado H, Newsom D, White P, et al. Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis. PLoS One. 2012;7(3):e33897.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med. 2009;22(2):124–8.

    Article  PubMed  Google Scholar 

  34. Gilstrap 3rd LC, Ramin SM. Urinary tract infections during pregnancy. Obstet Gynecol Clin N Am. 2001;28(3):581–91.

    Article  Google Scholar 

  35. Simmons LE, Rubens CE, Darmstadt GL, Gravett MG. Preventing preterm birth and neonatal mortality: exploring the epidemiology, causes, and interventions. Semin Perinatol. 2010;34:408–15.

    Article  PubMed  Google Scholar 

  36. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin N Am. 1997;11(1):135–76.

    Article  CAS  Google Scholar 

  37. Oda N, Takeuchi K, Tanaka A, Maruo T. Obstetric risk factors associated with the development of periventricular leukomalacia in preterm infants born to mothers complicated by placenta previa. Fetal Diagn Ther. 2008;24:345–8.

    Article  PubMed  Google Scholar 

  38. Nicolle LE. Screening for asymptomatic bacteriuria in pregnancy. The Canadian guide to clinical preventive health care. The Canadian Task Force on the Periodic Health Examination, ed. Ottawa: Canada Communication Group, 1994: 100–6.

  39. Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol. 2008;198:7–22.

    Article  PubMed  Google Scholar 

  40. Neal Jr DE. Complicated urinary tract infections. Urol Clin N Am. 2008;35:13–22.

    Article  Google Scholar 

  41. Lin K, Fajardo K, U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008;149:137.

    Google Scholar 

  42. Lin KW, Brown T. Screening for asymptomatic bacteriuria in adults. Am Fam Physician. 2010;81:508.

    PubMed  Google Scholar 

  43. MacLean AB. Urinary tract infection in pregnancy. Int J Antimicrob Agents. 2001;17:273–6. discussion: 276–277.

    Article  CAS  PubMed  Google Scholar 

  44. McIsaac W, Carroll JC, Biringer A, Bernstein P, Lyons E, Low DE, et al. Screening for asymptomatic bacteriuria in pregnancy. J Obstet Gynaecol Can. 2005;27(1):20–4.

    PubMed  Google Scholar 

  45. Stenqvist K, Kahlen-Nilsson I, Lidin-Janson G, et al. Bacteriuria in pregnancy: frequency and risk of acquisition. Am J Epidemiol. 1989;129:372–9.

    CAS  PubMed  Google Scholar 

  46. Wadland WC, Plante DA. Screening for asymptomatic bacteriuria in pregnancy: a decision and cost analysis. J Fam Pract. 1989;29:372–6.

    CAS  PubMed  Google Scholar 

  47. Rouse DJ, Andrews WW, Goldenberg RL, Owen J. Screening and treatment of asymptomatic bacteriuria of pregnancy to prevent pyelonephritis: a cost-effectiveness and cost-beneficial analysis. Obstet Gynecol. 1995;86:119–23.

    Article  CAS  PubMed  Google Scholar 

  48. Adam T, Lim SS, Mehta S, et al. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ. 2005;331(7525):1107.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, de Bernis L. Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet. 2005;365(9463):977–88.

    Article  PubMed  Google Scholar 

  50. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 15;40(10): 1556.

  51. Akerele J, Abhulimen P, Okonofua F. Prevalence of asymptomatic bacteriuria among pregnant women in Benin City. Niger J Obstet Gynaecol. 2001;21(2):141–4.

    Article  CAS  Google Scholar 

  52. Villar J, Lydon-Rochelle MT, Gulmezoglu AM, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 2000;2, CD000491.

    PubMed  Google Scholar 

  53. Widmer M, Gülmezoglu AM, Mignini L, Roganti A. Duration of treatment for asymptomatic bacteriuria during pregnancy. Cochrane Database Syst Rev. 2011;12, CD000491.

    PubMed  Google Scholar 

  54. Pohl A. Modes of administration of antibiotics for symptomatic severe urinary tract infections. Cochrane Database Syst Rev 2007: CD003237.72

  55. Wing DA. Pyelonephritis in pregnancy: treatment options for optimal outcomes. Drugs. 2001;61:2087–96.

    Article  CAS  PubMed  Google Scholar 

  56. Food US, Administration D. United States FDA pharmaceutical pregnancy categories. Fed Regist. 1980;44:37434–67.

    Google Scholar 

  57. Bánhidy F, Lowry RB, Czeizel AE. Risk and benefit of drug use during pregnancy. Int J Med Sci. 2005;2(3):100–6.

    Article  PubMed Central  PubMed  Google Scholar 

  58. Rakusan K. Drugs in pregnancy: implications for a cardiologist. Exp Clin Cardiol. 2010;15:e100–3.

    PubMed Central  PubMed  Google Scholar 

  59. Drugs during pregnancy and lactation: treatment options and risk assessment / edited by Christof Schaefer, Paul Peters and Richard K. Miller. 2nd edition: Elsevier, cop. 2007. Amsterdam.

  60. Guinto VT, De Guia B, Festin MR, Dowswell T. Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev, 2010. CD007855.

  61. Einarson A, Shuhaiber S, Koren G. Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs. 2001;3:803–16.

    Article  CAS  PubMed  Google Scholar 

  62. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 7. Philadelphia, PA: Lippincott Williams & Wilkins; 2005. p. 74.p. 268.p. 1153.

  63. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study. Am J Obstet Gynecol. 2001;184(6):1289–96.

    Article  CAS  PubMed  Google Scholar 

  64. Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol. 2004;58:298–302.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  65. Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother. 2000;46(Suppl A):29–34.

    Article  CAS  Google Scholar 

  66. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. A population-based case-control teratologic study of ampicillin treatment during pregnancy. Am J Obstet Gynecol. 2001;185:140–7.

    Article  CAS  PubMed  Google Scholar 

  67. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects. National birth defects prevention study. Arch Pediatr Adolesc Med. 2009;163(11):978–85.

    Article  PubMed  Google Scholar 

  68. Mitchell TF, Pearlman MD, Chapman RL, Bhatt-Mehta V, Faix RG. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol. 2001;98:1075–9.

    Article  Google Scholar 

  69. Källén B, Otterblad AJ, Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol. 2005;20:209–14.

    Article  PubMed  Google Scholar 

  70. Drinkard CR, Shatin D, Clouse J. Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. Pharmacoepidemiol Drug Saf. 2000;9:549–56.

    Article  CAS  PubMed  Google Scholar 

  71. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A teratological study of lincosamides. Scand J Infect Dis. 2000;32:579–80.

    Article  CAS  PubMed  Google Scholar 

  72. Kenyon S, Pike K, Jones DR, Brocklehurst P, Marlow N, Salt A, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet. 2008;372:1319–27.

    Article  CAS  PubMed  Google Scholar 

  73. Repchinsky C. Sulfamethoxazole/trimethoprim. Compendium of pharmaceuticals and specialties. The Canadian drug reference for health professionals. Canadian Pharmacists Association 2007; 2254–8.

  74. ACOG educational bulletin. Antimicrobial therapy for obstetrics patients. Number 245. Int J Gynecol Obstet. 1998;61:299–308.

    Google Scholar 

  75. Milo G, Katchman EA, Paul M, Christiaens T, Baerheim A, Leibovici L. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database Syst Rev, 2005. CD004682.

  76. Shephard TH, Brent RL, Friedman JM, Jones KL, Miller RK, Moore CA, et al. Update on new developments in the study of human teratogens. Teratology. 2002;65:153–61.

    Article  Google Scholar 

  77. Larsen H, Nielsen GL, Schønheyder HC, Olesen C, Sørensen HT. Birth outcome following maternal use of fluoroquinolones. Int J Antimicrob Agents. 2001;18:259–62.

    Article  CAS  PubMed  Google Scholar 

  78. Czeizel AE, Rockenbauer M, Sørensen HT, Olsen J. Nitrofurantoin and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):119–26.

    Article  CAS  PubMed  Google Scholar 

  79. Mantovani A, Macri C, Stazi AV, Ricciardi C, Guastadisegni C, Maranghi F. Tobramycin-induced changes in renal histology of fetal and newborn Sprague-Dawley rats. Teratog Carcinog Mutagen. 1992;12:19–30.

    Article  CAS  PubMed  Google Scholar 

  80. Diav-Citrin O, Gotteiner T, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome following gestational exposure to metronidazole: a prospective controlled cohort study. Teratology. 2001;63:186–92.

    Article  CAS  PubMed  Google Scholar 

  81. Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, et al. A randomized controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG. 2006;113(1):65–74.

    Article  CAS  PubMed  Google Scholar 

  82. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin N Am. 2003;17:227–41.

    Article  Google Scholar 

  83. Schneeberger C, Geerlings SE, Middleton P, Crowther CA. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009279. DOI: 10.1002/14651858.CD009279.pub2.

  84. Vazquez JC, Abalos E. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst Rev. 2011;1, CD002256.

    PubMed  Google Scholar 

  85. Usta TA, Dogan O, Ates U, Yucel B, Onar Z, Kaya E. Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. Int J Gynecol Obstet. 2011;114(3):229–33.

    CAS  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Yanira Ortega González and David Castro-Diaz do not have any conflicts of interest to declare.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Castro-Diaz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ortega-González, Y., Castro-Diaz, D. Antibiotic Considerations for Urinary Tract Infections in Pregnancy. Curr Bladder Dysfunct Rep 9, 167–174 (2014). https://doi.org/10.1007/s11884-014-0245-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-014-0245-8

Keywords

Navigation